ArticlePDF Available

Inhibition of Listeria monocytogenes in Fresh Cheese Using a Bacteriocin-Producing Lactococcus lactis CAU2013 Strain

Authors:

Abstract

In recent years, biocontrol of foodborne pathogens has become a concern in the food industry, owing to safety issues. Listeria monocytogenes is one of the foodborne pathogens that causes listeriosis. The major concern in the control of L. monocytogenes is its viability as it can survive in a wide range of environments. The purpose of this study was to isolate lactic acid bacteria with antimicrobial activity, evaluate their applicability as a cheese starter, and evaluate their inhibitory effects on L. monocytogenes. Lactococcus lactis strain with antibacterial activity was isolated from raw milk. The isolated strain was a low acidifier, making it a suitable candidate as an adjunct starter culture. The commercial starter culture TCC-3 was used as a primary starter in this study. Fresh cheese was produced using TCC-3 and L. lactis CAU2013 at a laboratory scale. Growth of L. monocytogenes (5 Log CFU/g) in the cheese inoculated with it was monitored during the storage at 4°C and 10°C for 5 days. The count of L. monocytogenes was 1 Log unit lower in the cheese produced using the lactic acid bacteria strain compared to that in the cheese produced using the commercial starter. The use of bacteriocin-producing lactic acid bacteria as a starter culture efficiently inhibited the growth of L. monocytogenes. Therefore, L. lactis can be used as a protective adjunct starter culture for cheese production and can improve the safety of the product leading to an increase in its shelf-life.
1
TITLE PAGE
1
- Korean Journal for Food Science of Animal Resources -
2
Upload this completed form to website with submission
3
4
ARTICLE INFORMATION
Fill in information in each box below
Article Type
Research article
Article Title
Inhibition of Listeria monocytogenes in fresh chees using a bacteriocin-
producing Lactococcus lactis CAU2013 strain
Running Title (within 10 words)
Biocontrol of L. monocytogenes in fresh cheese
Author
Sung-Hee Yoon1, Geun-Bae Kim1
Affiliation
1 Chung-Ang University, Anseong, Korea
Special remarks if authors have
additional information to inform the editorial
office
ORCID (All authors must have ORCID)
https://orcid.org
Sung-Hee Yoon (https://orcid.org/0000-0002-6826-0840)
Geun-Bae Kim (https://orcid.org/0000-0001-8531-1104)
Conflicts of interest
List any present or potential conflict s of
interest for all authors.
(This field may be published.)
The authors declare no potential conflict of interest.
Acknowledgements
State funding sources (grants, funding
sources, equipment, and supplies). Include
name and number of grant if available.
(This field may be published.)
Author contributions
(This field may be published.)
Conceptualization: Kim GB
Data curation: Yoon SH, Kim GB
Investigation: Yoon SH, Kim GB
Writing - original draft: Yoon SH
Writing - review & editing: Yoon SH, Kim GB
Ethics approval (IRB/IACUC)
(This field may be published.)
This manuscript does not require IRB/IACUC approval because there are
no human and animal participants.
5
CORRESPONDING AUTHOR CONTACT INFORMATION
6
For the corresponding author
(responsible for correspondence,
proofreading, and reprints)
Fill in information in each box below
First name, middle initial, last name
Geun-Bae Kim
Email address this is where your proofs
will be sent
kimgeun@cau.ac.kr
Secondary Email address
Postal address
17546
Cell phone number
010-7225-5986
Office phone number
031-670-3027
Fax number
7
8
2
Abstract
9
In recent years, biocontrol of foodborne pathogens has become a concern in the food industry,
10
owing to safety issues. Listeria monocytogenes is one of the foodborne pathogens that causes
11
listeriosis. The major concern in the control of L. monocytogenes is its viability as it can survive
12
in a wide range of environments. The purpose of this study was to isolate lactic acid bacteria
13
with antimicrobial activity, evaluate their applicability as a cheese starter, and evaluate their
14
inhibitory effects on L. monocytogenes.
15
Lactococcus lactis strain with antibacterial activity was isolated from raw milk. The isolated
16
strain was a low acidifier, making it a suitable candidate as an adjunct starter culture. The
17
commercial starter culture TCC-3 was used as a primary starter in this study. Fresh cheese was
18
produced using TCC-3 and La. lactis CAU2013 at a laboratory scale. Growth of L.
19
monocytogenes (5 log CFU/g) in the cheese inoculated with it was monitored during the storage
20
at 4℃ and 10℃ for 5 days. The count of L. monocytogenes was 1 log unit lower in the cheese
21
produced using the lactic acid bacteria strain compared to that in the cheese produced using the
22
commercial starter.
23
The use of bacteriocin-producing lactic acid bacteria as a starter culture efficiently inhibited
24
the growth of L. monocytogenes. Therefore, La. lactis can be used as a protective adjunct starter
25
culture for cheese production and can improve the safety of the product leading to an increase
26
in its shelf-life.
27
Keywords: Lactococcus lactis, bacteriocin, Listeria monocytogenes, cheese starter culture,
28
foodborne pathogen
29
3
Introduction
30
Listeriosis is a foodborne disease caused by Listeria monocytogenes. It can lead to sepsis,
31
meningitis, encephalitis, and even death (de Noordhout et al., 2014). Despite its low incidence
32
compared with that of other foodborne illnesses, listeriosis is one of the major issues in the food
33
industry because of its high fatality rate. L. monocytogenes is found in dairy products,
34
particularly in ready-to-eat cheese products. As L. monocytogenes survives in various
35
environments such as a those with a wide range of temperature (0–45℃) and pH (4.1–9.6), it
36
can contaminate cheese at several stages of production; therefore, its growth is difficult to
37
control (Lungu et al., 2008; Melo et al., 2014).
38
Several methods have been used to control the growth of L. monocytogenes in cheese,
39
including using bacteriocin or bacteriocin-producing lactic acid bacteria (LAB). Bacteriocins
40
are peptides or proteins, ribosomally synthesized by bacteria, which have antimicrobial ability
41
against closely related species. The application of bacteriocin-producing bacteria is
42
advantageous as they are stable, cost-effective, and safe. Anti-listerial activity of LAB in cheese
43
have also been reported (Coelho et al., 2014; Dal Bello et al., 2012; Kondrotiene et al., 2018).
44
In the present study, we aimed to determine the effects of bacteriocin-producing LAB isolated
45
from raw milk on the growth of L. monocytogenes in milk broth and cheese.
46
4
47
Materials and Methods
48
Isolation of bacteriocin-producing lactic acid bacteria
49
Potential bacteriocin-producing LAB were isolated from raw bovine milk, obtained from a
50
Chung-Ang University-affiliated farm (Anseong, Republic of Korea). The sample was serially
51
diluted ten-fold and plated on MRS agar (BD Difco, USA). The plates were incubated at 37℃
52
for 24–48 h, and a total of 90 well-isolated colonies were collected. Each colony was inoculated
53
into MRS broth for 24 h at 37℃.
54
To screen for antimicrobial activity, the cell-free supernatant (CFS) was obtained after
55
neutralization with 1N NaOH, centrifugation at 13,000 rpm for 10 min at 4℃, and filtered
56
through 0.45 µm filters to remove bacterial cells. Then, each supernatant was spotted on the
57
tryptic soy agar (TSA, BD Difco, USA) plate inoculated with a lawn of Listeria monocytogenes
58
ATCC 19115 as an indicator strain. The plates were incubated at 30℃ for 12 h, and antibacterial
59
activity was confirmed with the presence of inhibition zone. The strains with antibacterial
60
activity were routinely cultured in MRS broth at 37℃ overnight and were preserved in 10%
61
skim milk supplemented with 25% (v/v) glycerol, stored at -80℃ for further use.
62
63
Identification of bacteriocin-producing strain
64
The bacteriocin-producing strains were identified by Gram staining, carbohydrate
65
fermentation profile (analytical profile index (API) test), and 16S rRNA gene sequencing
66
analysis. Gram staining and API analysis was performed using a Gram-stain kit (BD Difco,
67
USA) and API 50 CHL kit (Biomérieux, France), respectively, according to the manufacturer’s
68
instructions.
69
5
For 16S rRNA analysis, the genomic DNA was extracted using QIAamp PowerFecal DNA
70
Kit (Qiagen, Germany) and amplified using 2X H-star Taq PCR Master Mix (BioFACT,
71
Republic of Korea). Polymerase chain reaction (PCR) was performed using the universal
72
bacterial primers 27F (5′-AGAGTTTGATCMTGG CTCAG-3′), 1492R (5′-
73
TACGGYTACCTTGTTACGACTT-3′), 785F (5′-GGATTAGA TACCCTGGTA-3′), and 805R
74
(5′-GACTACCAGGGTATCTAATC-3′). The PCR products were purified using a PCR
75
purification kit (Qiagen, Germany) and sequenced by SolGent Co. Ltd. (Daejon, Republic of
76
Korea).
77
The analyzed sequences were confirmed using the EzTaxon-e server (www.ezbiocloud.net/)
78
(Kim et al., 2012) and NCBI GenBank database using the Basic Local Alignment Search Tool
79
(BLAST) algorithm (https://blast.ncbi.nlm.nih.gov/Blast.cgi) (Altschul et al., 1990).
80
81
Antibacterial activity of bacteriocin
82
Bacteriocin activity was assessed using a spot-on-lawn method as described previously
83
(Phumisantiphong et al., 2017) with minor modifications. Briefly, each indicator strain was
84
inoculated to 4 mL of molten TSA and overlaid on the base TSA plate. After solidification, 20
85
µL of the neutralized CFS of LAB strains was spotted onto the indicator lawn. After incubation
86
at 30℃ for 12 h, a clear inhibition zone was observed. The foodborne pathogens used as
87
indicator strains were cultured in tryptic soy broth (TSB, BD Difco, USA) at 37℃ overnight
88
before use. The experiment was conducted in triplicates.
89
90
Evaluation of acid production
91
The acid production of the La. lactis CAU2013 was evaluated and compared with that of the
92
commercial starter TCC-3 (Chr. Hansen, Denmark), which consisted of Lactobacillus
93
6
delbrueckii subsp. bulgaricus and Streptococcus thermophilus. The cultures were grown in
94
MRS broth at 37℃ overnight. Then, individual cultures and mixture of La. lactis CAU2013
95
and TCC-3 (1:1 ratio) were inoculated in 10% skim milk broth (Harrington and Hill, 1991) and
96
whole milk. The pH and titratable acidity (TA) were measured every three hours for 12 h while
97
incubating at 30℃. To determine TA, 0.1% phenolphthalein was used as an indicator, and 0.1
98
N sodium hydroxide (NaOH) for titration.
99
100
Anti-listerial activity of strain CAU2013 as an adjunct starter in milk
101
To determine the anti-listerial properties of strain CAU2013 when used as an adjunct starter
102
in milk, 10% skim milk broth and whole milk media were inoculated with an overnight culture
103
of CAU2013 and 1:1 ratio of CAU2013 and TCC-3 starter (final concentration of 7 log
104
CFU/mL). Additionally, the overnight culture of L. monocytogenes ATCC 19115 was
105
inoculated to each setup (final concentration of 5 log CFU/mL). The inoculated milk media
106
were incubated at 30℃ for 12 h. The viable cell count of L. monocytogenes was determined
107
every three hours. Samples were diluted serially in ten-fold increments using 1×phosphate-
108
buffered saline (PBS, pH7.5) and plated on Oxford agar (BD Difco, USA).
109
Manufacture of laboratory-scale cheese
110
The lab-scale cheese was manufactured following the methods of Mills et al.(2011) with
111
some modifications. TCC-3 was used as the primary starter and La. lactis CAU2013 as an
112
adjunct culture. The starter cultures were initially grown in MRS broth at 37℃ for 24 h before
113
inoculation into 10% skim milk broth and incubated for 18 h at 37℃ before use. Additionally,
114
L. monocytogenes ATCC19115 was cultured in TSB for 18 h at 37℃ before use.
115
Milk (400 mL) (Seoul milk, Republic of Korea) was heated to 31℃ before the inoculation of
116
starter culture. The starter cultures were inoculated as follows: TCC-3 and La. lactis CAU2013
117
7
and TCC-3 (1:1 ratio), both at a final concentration of 7 log CFU/mL. Subsequently, 0.01% L.
118
monocytogenes at a level of 5 log CFU/mL was inoculated into both treatments. After 30 min,
119
0.2 g/L of rennet was added, and the mixture was stirred for 2 min. Once coagulum formed
120
firmly, the curd was cut into cubes, and the mixture was stirred for 10 min. Then, the mixture
121
was heated to 36℃ for 10 min and stirred for 20 min. The whey was drained off, and curd was
122
distributed into the sterile dish. The samples were stored at 4℃ and 10℃ for 5 days. The
123
procedure of cheese production is illustrated in Figure 1.
124
125
Microbial analysis of laboratory-scale fresh cheese
126
The viable cell counts of LAB and L. monocytogenes in the lab-produced cheese were
127
determined in duplicate every day during storage at 4℃ and 10℃. For microbial analysis, 1 g
128
of cheese was homogenized in 9 mL of PBS buffer and were serially diluted ten-fold in the
129
same buffer and plated on the appropriate agar plate. The LABs were enumerated on MRS agar
130
after incubation at 37℃ for 3 days, and L. monocytogenes on Oxford agar after incubation at
131
37℃ for 24 h. All of the experiments were conducted in triplicates.
132
8
Results and discussion
133
Isolation and identification of bacteriocin-producing strains
134
Among the 90 colonies isolated from raw milk, one isolate exhibited antibacterial activity
135
against L. monocytogenes. The strain CAU2013 was characterized as a gram-positive, coccus-
136
shaped bacterium. The biochemical characteristics determined using the API 50 CHL kit are
137
described in Table 1. 16S rRNA gene sequence analysis revealed that strain CAU2013 is most
138
likely a strain of Lactococcus lactis (Table 2), which commonly produce nisin (Shin et al.,
139
2016). Neighbor-joining (NJ) phylogenetic tree of the strain CAU 2013 and related type strains
140
based on 16S rRNA gene sequences also clearly show that this strain belongs to Lactococcus
141
lactis (Supplementary Figure 1). La. lactis strains are historically used in the fermentation and
142
preservation of food and are generally recognized as safe (GRAS) (Cook et al., 2018).
143
Therefore, La. lactis CAU2013 was selected for downstream applications in the study.
144
L. monocytogenes ATCC 19115 was used as an indicator strain for all experiments because it
145
belongs to the serotype 4b, which causes most cases of listeriosis.
146
147
Antibacterial activity of bacteriocin
148
The bacteriocin produced by La. lactis CAU2013 had antibacterial activity against all Listeria
149
strains as well as Staphylococcus aureus, which are common foodborne pathogens (Yoon,
150
2020). However, no antibacterial activity was observed against other gram-positive foodborne
151
pathogens, such as Salmonella enteritidis and Escherichia coli (Table 3). Generally, nisin is
152
highly effective against gram-positive bacteria by binding to lipid Ⅱ, which leads to the
153
inhibition of cell wall biosynthesis or pore formation in the membrane. However, nisin cannot
154
9
bind to its target lipid II in gram-negative bacteria, because of the presence of the outer
155
membrane (Li et al., 2018).
156
157
Characterization of acid production
158
The changes in pH and TA values in 10% skim milk broth and in whole milk are presented
159
in Figure 2. La. lactis CAU2013 reduced the pH of skim milk broth from 6.41 to 5.77 and that
160
of whole milk from 6.65 to 6.20. Additionally, TA value increased to 0.25 in both broths. Ayad
161
et al. (2004) described fast, medium, or slow-acidifying strains as pH(=pHat time-pHzero time)
162
of 0.4 U achieved after 3 h, 3–5 h, and > 5 h, respectively. Also, Raquib et al. (2003) classified
163
strains with titratable acidity as low, moderate, or fast when the TA values were < 0.5, between
164
0.5 and 0.6, and > 0.6, respectively. Therefore, La. lactis CAU2013 can be classified as a low
165
acidifier strain. This result is consistent with other studies that reported poor acid production
166
from La. lactis strains (Ayad et al., 2004; Coelho et al., 2014).
167
The pH values measured corresponded with the calculated TA and were generally similar for
168
skim milk broth and whole milk. The mixed starter, consisting of TCC-3 and La. lactis
169
CAU2013, accelerated the acidification in milk. Nevertheless, bacteriocin-producing strains
170
delay acidification (Garde et al., 1997); however, the strain CAU2013 did not show similar
171
properties. The accelerated acidification might be because of the interaction between the strains;
172
however, the underlying mechanisms need further research. Ávila et al. (2005) observed that
173
enterocin-producing adjunct starter enterococci enhanced milk acidification, which may be
174
stimulated by the low-molecular-weight nitrogen compounds produced by primary starter,
175
Lactobacillus helveticus LH92.
176
The rapid decline in pH during the initial stage of cheese production is crucial for curd
177
10
formation and prevention of the growth of undesirable microorganisms. Therefore, the fast-
178
acidifying strains can be used as primary starters, while the slow-acidifying bacteria can be used
179
as adjunct starters. As the strain CAU2013 has antibacterial property but has low acid
180
production ability, it is better suited as an adjunct starter culture.
181
182
Anti-listerial activity of strain CAU2013 as an adjunct starter in milk
183
The growth of L. monocytogenes was monitored in skim milk broth and whole milk during
184
incubation at 30℃. In skim milk broth with La. lactis CAU2013, the concentration of L.
185
monocytogenes count was reduced by 3 log units more compared with that of other samples
186
after 3 h and not detected following 6 h of fermentation (Figure 3a). In the whole milk with the
187
strain CAU2013, L. monocytogenes count was reduced by 0.5 log unit after 6 h, and 1 log unit
188
after 9 h compared with that of other samples (Figure 3b).
189
The results support the findings from several studies that reported that the addition of
190
bacteriocin affects the biocontrol of spoilage bacteria. Muñoz et al. (2007) investigated that E.
191
faecalis-produced enterocin in milk and found that it could control the growth of
192
Staphylococcus aureus. In addition, according to Arqués et al. (2011), the addition of nisin in
193
milk decreased L. monocytogenes count by 3 log units after 4 h.
194
The efficiency of the combined starter cultures in the inhibition of L. monocytogenes was
195
lower in whole milk than in skim milk. The difference in the composition between the two milk
196
media could be a factor responsible for the difference. In addition, Muñoz et al. (2007) stated
197
that low effectiveness in foods could be attributed to higher retention of the bacteriocin
198
molecules by milk components, resulting in slower diffusion. However, in both cases, inhibition
199
of L. monocytogenes growth was observed. The results suggest the potential application of La.
200
lactis CAU2013 in various food systems to control L. monocytogenes growth.
201
11
202
Inhibition of L. monocytogenes in laboratory-scale fresh cheese
203
The cell count of the starter cultures was determined during the storage at 4℃ and 10℃
204
(Figure 4). In both the cases, LAB reached a final concentration of 9 log CFU/g during cheese
205
manufacture.
206
During the storage at 4℃, the cheese treated with TCC-3 starter culture maintained L.
207
monocytogenes count at 7.5 to 7.7 log CFU/g. In contrast, the cheese treated with TCC-3 and
208
La. lactis CAU2013 had less L. monocytogenes count, approximately 0.5 log unit at 0 h and 1
209
log unit after 5 days with a final concentration of 6.4 log CFU/g. Besides, during the storage at
210
10℃, the cheese treated with TCC-3 starter culture maintained the bacterial count between 6.86
211
and 7.31 log CFU/g (Figure 4a). within contrast, the cheese treated with TCC-3 and CAU2013
212
had less L. monocytogenes count, approximately 1 log unit at 0 h and 1.5 log unit after 5 days,
213
with a final concentration of 5.76 log CFU/g (Figure 4b). This result is consistent with a study
214
that reported that 2 log unit reduction was observed in cheese with La. lactis strain (Coelho et
215
al., 2014). Moreover, Kondrotiene et al. (2018) showed that nisin-producing La. lactis strains
216
decreased the growth of L. monocytogenes in fresh cheese during 7 days of storage at 4℃.
217
Therefore, the results support that manufacturing cheese using a bacteriocin-producing starter
218
reinforced the inhibition of growth of L. monocytogenes, and it would be effective in controlling
219
contamination during cheese production. Additionally, after storage at temperatures of 4℃ and
220
10℃, L. monocytogenes count was reduced, which may confirm the potential of LAB in
221
controlling the growth of L. monocytogenes during storage at refrigeration temperature.
222
223
Conflicts of interest
224
The authors declare no potential conflicts of interest.
225
12
226
Author contributions
227
Conceptualization: Kim GB. Data curation: Yoon SH, Kim GB. Investigation: Yoon SH, Kim
228
GB. Writing - original draft: Yoon SH. Writing - review & editing: Yoon SH, Kim GB.
229
230
Ethics Approval
231
This article does not require IRB/IACUC approval because there are no human and animal
232
participants.
233
234
References
235
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search
236
tool. J Mol Biol 215(3):403-410.
237
Arqués JL, Rodríguez E, Nuñez M, Medina M. 2011. Combined effect of reuterin and lactic
238
acid bacteria bacteriocins on the inactivation of food-borne pathogens in milk. Food
239
Control 22:457–461.
240
Ávila M, Garde S, Medina M, Nuñez M. 2005. Effect of milk inoculation with bacteriocin-
241
producing lactic acid bacteria on a Lactobacillus helveticus adjunct cheese culture. J Food
242
Prot 68(5):1026-1033.
243
Ayad EHE, Nashat S, El-Sadek N, Metwaly H, El-Soda M. 2004. Selection of wild lactic acid
244
bacteria isolated from traditional Egyptian dairy products according to production and
245
technological criteria. Food Microbiol 21:715-725.
246
Coelho MC, Silva CC, Ribeiro SC, Dapkevicius ML, Rosa HJ. 2014. Control of Listeria
247
monocytogenes in fresh cheese using protective lactic acid bacteria. Int J Food Microbiol
248
13
191:53-59.
249
Cook DP, Gysemans C, Mathieu C. 2018. Lactococcus lactis as a versatile vehicle for
250
tolerogenic immunotherapy. Front Immunol 8:1961.
251
Dal Bello B, Cocolin L, Zeppa G, Field D, Cotter PD, Hill C. 2012. Technological
252
characterization of bacteriocin producing Lactococcus lactis strains employed to control
253
Listeria monocytogenes in cottage cheese. Int J Food Microbiol 153:58-65.
254
de Noordhout CM, Devleesschauwer B, Angulo FJ, Verbeke G, Haagsma J, Kirk M, Havelaar
255
A, Speybroeck N. 2014. The global burden of listeriosis: a systematic review and meta-
256
analysis. Lancet Infect Dis 14(11):1073–1082.
257
Garde S, Gaya P, Medina M, Nuñez M. 1997. Acceleration of flavour formation in cheese by
258
a bacteriocin-producing adjunct lactic culture. Biotechnol Lett 19:1011–1014.
259
Kim OS, Cho YJ, Lee K, Yoon SH, Kim M, Na H, Park SC, Jeon YS, Lee JH, Yi H, Won S,
260
Chun J. 2012. Introducing EzTaxon-e: a prokaryotic 16S rRNA gene sequence database
261
with phylotypes that represent uncultured species. Int J Syst Evol Microbiol 62:716–721.
262
Kondrotiene K, Kasnauskyte N, Serniene L, Gölz G, Alter T, Kaskoniene V, Maruska AS,
263
Malakauskasa M. 2018. Characterization and application of newly isolated nisin producing
264
Lactococcus lactis strains for control of Listeria monocytogenes growth in fresh cheese.
265
LWT Food Sci Technol 87:507–514.
266
Li Q, Montalban-Lopez M, Kuipers OP. 2018. Increasing the antimicrobial activity of nisin-
267
based lantibiotics against Gram-negative pathogens. Appl Environ Microbiol
268
84(12):e00052-18.
269
Lungu B, Ricke SC, Johnson MG. 2008. Growth, survival, proliferation and pathogenesis of
270
Listeria monocytogenes under low oxygen or anaerobic conditions: A review. Food
271
14
Microbiol 15:7-17.
272
Melo J, Andrew PW, Faleiro ML. 2014. Listeria monocytogenes in cheese and the dairy
273
environment remains a food safety challenge: The role of stress responses. Food Res Int
274
67: 75-90.
275
Mills S, Serrano LM, Griffin C, O’Connor PM, Schaad G, Bruining C, Hill C, Ross RP, Meijer
276
WC. 2011. Inhibitory activity of Lactobacillus plantarum LMG P-26358 against Listeria
277
innocua when used as an adjunct starter in the manufacture of cheese. Microb Cell Fact
278
10(suppl 1):S7.
279
Muñoz A, Ananou S, Gálvez A, Martínez-Bueno M, Rodríguez A, Maqueda M, Valdivia E.
280
2007. Inhibition of Staphylococcus aureus in dairy products by enterocin AS-48 produced
281
in situ and ex situ: bactericidal synergism with heat. Int Dairy J 17:760–769.
282
Phumisantiphong U, Siripanichgon K, Reamtong O, Diraphat P. 2017. A novel bacteriocin from
283
Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant
284
enterococci. PLoS ONE 12(10):e0186415.
285
Raquib M, Trishna B, Choudary RK, Rahaman H, Borpuzari T. 2003. Isolation and
286
characterization of lactobacilli isolate from market sample of sour dahi. Indian Vet J
287
80:791-794.
288
Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL. 2016. Biomedical
289
applications of nisin. J Appl Microbiol 120(6):1449-1465.
290
Yoon SH. 2020. Application of bacteriocin-producing lactic acid bacteria in fresh cheese for
291
efficient control of Listeria monocytogenes. MSc Thesis, Chung-Ang University.
292
293
15
Table 1. Carbohydrate fermentation patterns of the two isolated bacteriocin-producing lactic
294
acid bacteria. The test was performed with API 50 CHL kit and all data are from this study. +,
295
positive; -, negative
296
Carbohydrates
Glycerol
-
+
Erythritol
-
+
D-arabinose.
-
+
L-arabinose
+
+
D-ribose
+
-
D-xylose
+
+
L-xylose
-
+
D-xylose
-
-
Methyl-beta-D-xylopyranoside
-
+
D-galactose
+
-
D-glucose
+
+
D-fructose
+
-
D-mannose
+
-
L-sorbose
-
+
L-rhamnose
-
-
Dulcitol
-
-
Inositol
-
+
D-mannitol
+
-
D-sorbitol
-
-
Methyl-alpha-D-
mannopyranoside
-
-
Methyl-alpha-D-
glucopyranoside
-
-
N-acetylglucosamine
+
-
Amygdalin
+
-
Arbutin
+
-
Esculin ferric citrate
+
297
16
Table 2. Identification of bacteriocin-producing strains by BLAST and Ez-Taxon.
298
BLAST
EzTaxon
Strain
Taxon name
Similarity
(%)
Taxon name
Similarity
(%)
CAU2013
Lactococcus lactis subsp. lactis
100
Lactococcus lactis subsp. lactis
100
Lactococcus lactis subsp.
hordniae
99.86
Lactococcus lactis subsp.
hordniae
99.86
Lactococcus lactis subsp. tructae
99.39
Lactococcus lactis subsp. tructae
99.39
299
300
301
Table 3. Antimicrobial spectrum of bacteriocin from L. lactis CAU2013. +, < 10 mm; ++, >
302
10 mm; -, no inhibition zone.
303
Indicator strain
Inhibition activity
Gram positive
L. monocytogenes ATCC
15315
+
L. monocytogenes ATCC 7644
++
L. monocytogenes ATCC
19111
+
L. monocytogenes ATCC
19114
++
L. monocytogenes ATCC
19115
++
Staphylococcus aureus
RN6390
+
Gram negative
Salmonella enteritidis YHS
383
-
Escherichia coli ATCC 25922
-
17
Figure 1. The procedure of lab-scale fresh cheese production.
304
305
18
306
Figure 2. The values of pH and titratable acidity (TA) of strains grown in 10% skim milk and
307
whole milk at 30℃. (A) pH values and (B) TA values in 10% skim milk, (C) pH values and
308
(D) TA values in whole milk. TCC-3 (■), L. lactis CAU2013 (●), and the combination of
309
TCC-3 with CAU2013 (▲).
310
311
312
313
314
315
3.00
3.50
4.00
4.50
5.00
5.50
6.00
6.50
7.00
0 3 6 9 12 15
pH
Time (h)
TCC-3 CAU2013 TCC+CAU2013
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0 3 6 9 12 15
TA (%)
Time (h)
TCC-3 CAU2013 TCC+CAU2013
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0 3 6 9 12
TA (%)
Time (h)
TCC-3 CAU2013 TCC+CAU2013
3.00
3.50
4.00
4.50
5.00
5.50
6.00
6.50
7.00
0 3 6 9 12
pH
Time (h)
TCC-3 CAU2013 TCC+CAU2013
(A)
(B)
(D)
(C)
19
Figure 3. Biocontrol of L. monocytogenes in 10% skim milk broth and whole milk. L.
316
monocytogenes was inoculated in milk broth (A) and whole milk (B), and incubated at 30℃
317
without starter (●), or with 1 % of TCC-3 (▲), or the combination of TCC-3 and CAU2013
318
(■).
319
320
321
322
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
0 3 6 9 12
Log (CFU/mL)
Time (h)
control TCC TCC + CAU2013
4.00
5.00
6.00
7.00
8.00
0 3 6 9 12
Log (CFU/mL)
Time (h)
control TCC TCC + CAU2013
(B)
(A)
20
Figure 4. The viable cell counts of L. monocytogenes and LAB in fresh cheese manufactured
323
with TCC-3 starter and combination of L. lactis CAU2013 and TCC-3 and then stored for 5
324
days. During the storage at 4℃ (A) and 10℃ (B), LAB in cheese produced with TCC-3 (●);
325
TCC-3 and CAU2013 (■) were measured. Also, L. monocytogenes was measured in cheese
326
with TCC-3 () and cheese with mixed starter ().
327
328
5.00
6.00
7.00
8.00
9.00
10.00
0 1 2 3 4 5
Log (CFU/g)
Time (Day)
TCC TCC+CAU2013 TCC(LAB) TCC+CAU2013(LAB)
5.00
6.00
7.00
8.00
9.00
10.00
012345
Log (CFU/g)
Time (Day)
TCC TCC+CAU2013 TCC(LAB) TCC+CAU2013
(B)
(A)
21
329
... In fact, bacteriocinogenic strains (bacteriocin producers) could be applied directly in foods, allowing for in situ production and effectiveness in reducing foodborne pathogens, such as L. monocytogenes. This approach has been proven during different investigations [37,38]. Furthermore, processes also consist of using purified or semi-purified bacteriocins. ...
Article
Full-text available
The development of new techniques for the control of pathogenic microorganisms during food production and for the prevention of spoilage are needed to reduce or replace chemical preservatives. This is due to the trend that consumers are increasingly questioning the use of chemical preservatives because of the many health concerns. Because of this issue, bacteriocins and bacteriophages are increasingly viewed as safe natural preservatives with a long history of various applications during food production and preservation. This minireview considers applications of these two antimicrobials, highlights their mode of action, lists their advantages and, when necessary, their limitations. It also reports recent advances in the use of bacteriophages and bacteriocins either alone or in combination in different food matrices. The incentives and effectiveness offered by these antimicrobials in the field of biopreservation are considered for future applications during food production and preservation.
... All the 130 enzymes were purchased from Sigma-Aldrich (USA). After boiling for 5 min at 80℃ to inactivate enzymes, 131 the anti-listerial activity of the samples was evaluated by the agar well diffusion method (Yoon et al, 2022). 132 ...
Article
Full-text available
Among various biological agents, bacteriocins are important candidates to control Listeria monocytogenes which is a foodborne pathogen. In this study, a novel bacteriocin, named agilicin C7, was isolated from Ligilactobacillus agilis C7 showing inhibitory activity against L. monocytogenes. Agilicin C7 biosynthesis gene was characterized by bioinformatics analyses and heterologously expressed in Escherichia coli for further study. The anti-listeria activity of recombinant agilicin C7 (r-agilicin C7) was lost by proteases and α-amylase, suggesting that agilicin C7 is a glycoprotein. r-Agilicin C7 has wide pH and thermal stability and is also stable in various organic solvents. It destroyed L. monocytogenes by damaging the integrity of the cell envelope. These properties of r-agilicin C7 indicate that agilicin C7 is a novel amylase-sensitive anti-listerial Class IId bacteriocin. Physicochemical stability and inhibitory activity against L. monocytogenes of r-agilicin C7 suggest that it can be applied to control L. monocytogenes in the food industry, including dairy and meat products.
Article
Full-text available
A number of non-thermal preservation strategies have been adopted from the dairy industry to improve cheese quality and safety. The application of lactic acid bacteria cultures that produce bacteriocins has been extensively studied as a means of bio-preservation. However, the application of purified bacteriocins as a bio-protective agent is limited in cheese. The application of protective cultures is another strategy, and the aim of the current review is to provide an overview of the application of commercial and autochthonous adjunct cultures on the bio-protection of cheese; both public health and spoilage aspects are considered.
Article
Full-text available
This study aimed to analyze the leading research materials and research trends related to livestock food in Asia in recent years and propose future research agendas to ultimately contribute to the development of related livestock species. On analyzing more than 200 relevant articles, a high frequency of studies on livestock species and products with large breeding scales and vast markets was observed. Asia possesses the largest pig population and most extensive pork market, followed by that of beef, chicken, and milk; moreover, blood and egg markets have also been studied. Regarding research keywords, “meat quality” and “probiotics” were the most common, followed by “antioxidants”, which have been extensively studied in the past, and “cultured meat”, which has recently gained traction. The future research agenda for meat products is expected to be dominated by alternative livestock products, such as cultured and plant-derived meats; improved meat product functionality and safety; the environmental impacts of livestock farming; and animal welfare research. The future research agenda for dairy products is anticipated to include animal welfare, dairy production, probiotic-based development of high-quality functional dairy products, the development of alternative dairy products, and the advancement of lactose-free or personalized dairy products. However, determining the extent to which the various research articles’ findings have been applied in real-world industry proved challenging, and research related to animal food laws and policies and consumer surveys was lacking. In addition, studies on alternatives for sustainable livestock development could not be identified. Therefore, future research may augment industrial application, and multidisciplinary research related to animal food laws and policies as well as eco-friendly livestock production should be strengthened.
Article
Full-text available
The objective of this experiment was to select D. hansenii isolates that are stable in dry fermented sausage (DFS) production and can positively affect the quality. D. hansenii isolates were examined for production of biogenic amines, β-glucuronidase, β-glucosidase, proteolytic, and lipolytic enzymatic activities. The acid and salt tolerance of D. hansenii isolates were also examined. DFS inoculated with selected D. hansenii isolates were analyzed for microorganisms, weight loss, Aw, and pH. DFS was also subjected to analyses of color, texture profile, reducing sugar, volatile basic nitrogen (VBN), lipid oxidation, and free fatty acid. Twenty-two D. hansenii isolates were isolated. None of these D. hansenii isolates produced biogenic amines, and all strains were negative for β-glucuronidase and β-glucosidase activities. After examining these strains for proteolysis, lipolysis, and salt and acid tolerance, D. hansenii isolates SMFM2021-C14, SMFM2021-S8, and SMFM2021-SL3 were selected to be used in DFS. During the processing of DFS, the groups treated with D. hansenii isolate SMFM2021-S8 or SMFM2021-SL3 showed lower (p < .05) hardness values of DFS. The sample treated with D. hansenii SMFM2021-S8 showed lower (p < .05) VBN and lipid oxidation contents than the others. The ratio of ω-6/ω-3 was lower (p < .05) in D. hansenii SMFM2021-SL3 treated group than in the other treatments. These results indicate that D. hansenii isolates SMFM2021-S8 and SMFM2021-SL3 might be useful in producing DFS to improve its quality.
Article
In this study, the characteristics of Listeria monocytogenes isolated from enoki mushroom ( Flammulina velutipes ) collected from May to July 2019 were analyzed. The isolates were analyzed for strain characteristics, hemolysis, antibiotic resistance, heat resistance, and virulence genes ( inlA , inlB , actA , plcB , and hlyA ) were analyzed, and whole genome sequencing (WGS) analysis was performed for the strain with the highest risk. Seven isolates were obtained from some enoki mushroom samples. All isolates were β‐hemolytic and had virulence genes. Antibiotic resistance test showed multi‐drug resistance in L . monocytogenes strain SMFM2019‐FV15 and SMFM2019‐FV16. L . monocytogenes SMFM2019‐FV16 showed higher heat resistance than the other isolates. According to the results L . monocytogenes SMFM2019‐FV16 was selected as the strain with the highest risk. WGS for L . monocytogenes SMFM2019‐FV16 showed that it had 14 antibiotic resistance genes and 43 virulence genes, and 35 single nucleotide variants in the 43 virulence genes were observed. These results indicate that these genetic variations might be related to the high risk of L . monocytogenes SMFM2019‐FV16.
Article
Full-text available
Lantibiotics are ribosomally synthesized and posttranslationally modified antimicrobial compounds containing lanthionine and methyl-lanthionine residues. Nisin, one of the most extensively studied and used lantibiotics, has been shown to display a very potent activity against Gram-positive bacteria and stable resistance is rarely observed. By binding to lipid II and forming pores in the membrane, nisin can cause efflux of cellular constituents and inhibit cell wall biosynthesis. However, the activity of nisin against Gram-negative bacteria is much lower than that against Gram-positive bacteria, mainly because lipid II is located at the inner-membrane and the rather impermeable outer-membrane in Gram-negative bacteria prevents nisin from reaching lipid II. Thus, if the outer-membrane traversing efficiency of nisin could be increased, the activity against Gram-negative bacteria could in principle be enhanced. In this work, several relatively short anti-Gram-negative peptides were selected from literature data, to be fused as tails to the C-terminus of either full or truncated nisin species. Among these, we found that three tails (T2: DKYLPRPRPV, T6:NGVQPKY and T8: KIAKVALKAL), attached to a part of nisin displayed improved activity against Gram-negative microorganisms. Next, we rationally designed and re-engineered the most promising fusion peptides. Several mutants that significantly outperformed nisin against Gram-negative pathogens were obtained. The activity of the construct T16m2 against several important Gram-negative pathogens (i.e. Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa , Enterobacter aerogenes ) was increased 4-12 fold compared to that of nisin. This study indicates that rational design of nisin can selectively and significantly improve its outer-membrane permeating capacity as well as its activity against Gram-negative pathogens. IMPORTANCE: Lantibiotics are antimicrobial peptides highly active against Gram-positive bacteria, but with a relatively poor activity against most Gram-negative bacteria. Here, we have modified the model lantibiotic, nisin, by fusing parts of it to antimicrobial peptides with known activity against Gram-negative bacteria. The appropriate selection of peptidic moieties that can be attached to (parts of) nisin can lead to a significant increase in its inhibitory activity against Gram-negative bacteria. Using this strategy, hybrids that outperform nisin were produced, displaying 4-12 fold higher activity against relevant Gram-negative species. This study shows the power of modified-peptide engineering to alter target specificity in a desired direction.
Article
Full-text available
Genetically modified Lactococcus lactis bacteria have been engineered as a tool to deliver bioactive proteins to mucosal tissues as a means to exert both local and systemic effects. They have an excellent safety profile, the result of years of human consumption in the food industry, as well as a lack of toxicity and immunogenicity. Also, containment strategies have been developed to promote further application as clinical protein-based therapeutics. Here, we review technological advancements made to enhanced the potential of L. lactis as live biofactories and discuss some examples of tolerogenic immunotherapies mediated by mucosal drug delivery via L. lactis. Additionally, we highlight their use to induce mucosal tolerance by targeted autoantigen delivery to the intestine as an approach to reverse autoimmune type 1 diabetes.
Article
Full-text available
The emergence of multidrug-resistant enterococci (MDRE) and particularly vancomycin-resistant enterococci (VRE) is considered a serious health problem worldwide, causing the need for new antimicrobials. The aim of this study was to discover and characterize bacteriocin against clinical isolates of MDRE and VRE. Over 10,000 bacterial isolates from water, environment and clinical samples were screened. E. faecalis strain 478 isolated from human feces produced the highest antibacterial activity against several MDRE and VRE strains. The optimum condition for bacteriocin production was cultivation in MRS broth at 37°C, pH 5–6 for 16 hours. The bacteriocin-like substance produced from E. faecalis strain EF478 was stable at 60°C for at least 1 hour and retained its antimicrobial activity after storage at -20°C for 1 year, at 4°C for 6 months, and at 25°C for 2 months. A nano-HPLC electrospray ionization multi-stage tandem mass spectrometry (nLC-ESI-MS/MS) analysis showed that the amino acid sequences of the bacteriocin-like substance was similar to serine protease of E. faecalis, gi|488296663 (NCBI database), which has never been reported as a bacteriocin. This study reported a novel bacteriocin with high antibacterial activity against VRE and MDRE.
Article
Full-text available
A total of 150 isolated lactobacilli strains were found to be gram positive rods or coccobacilli, catalase negative, nonspore former and nonmotile. Out of these 24 isolates were selected based on the acid production capacity and ability to reduce pH. Of the 24 isolates, 8 belonged to thermobacteria and the remaining 16 were of betabacteria group. Sugar fermentation test of the isolates revealed L. delbrueckii ssp. delbrueckii, L. delbrueckii ssp. bulgaricus, L. delbrueckii ssp, lactis, L. actdopilus to and L. casei ssp. tolerans. The isolated strain of lactobacilli, L. delbrueckii ssp. bulgaricus LDb53 and L. acidophilus LA68 could be successfully used as a mixed culture for dahi production with improved organoleptic characteristics and enhanced therapeutic benefits.
Article
Full-text available
Nisin is a bacteriocin produced by a group of Gram-positive bacteria that belongs to Lactococcus and Streptococcus species. Nisin is classified as a Type A (I) lantibiotic that is synthesized from mRNA and the translated peptide contains several unusual amino acids due to post-translational modifications. Over the past few decades, nisin has been used widely as a food biopreservative. Since then, many natural and genetically modified variants of nisin have been identified and studied for their unique antimicrobial properties. Nisin is an FDA approved and GRAS (generally regarded as safe) peptide with recognized potential for clinical use. Over the past two decades the application of nisin has been extended to biomedical fields. Studies have reported that nisin can prevent the growth of drug-resistant bacterial strains, such as methicillin resistant Staphylococcus aureus, Streptococcus pneumoniae, Enterococci and Clostridium difficile. Nisin has now been shown to have antimicrobial activity against both Gram-positive and Gram-negative disease-associated pathogens. Nisin has been reported to have anti-biofilm properties and can work synergistically in combination with conventional therapeutic drugs. In addition, like host defense peptides, nisin may activate the adaptive immune response and have an immunomodulatory role. Increasing evidence indicates that nisin can influence the growth of tumors and exhibit selective cytotoxicity towards cancer cells. Collectively, the application of nisin has advanced beyond its role as a food biopreservative. Thus, this review will describe and compare studies on nisin and provide insight into its future biomedical applications. This article is protected by copyright. All rights reserved.
Article
Full-text available
Listeriosis, caused by Listeria monocytogenes, is an important foodborne disease that can be difficult to control and commonly results in severe clinical outcomes. We aimed to provide the first estimates of global numbers of illnesses, deaths, and disability-adjusted life-years (DALYs) due to listeriosis, by synthesising information and knowledge through a systematic review. METHODS: We retrieved data on listeriosis through a systematic review of peer-reviewed and grey literature (published in 1990-2012). We excluded incidence data from before 1990 from the analysis. We reviewed national surveillance data where available. We did a multilevel meta-analysis to impute missing country-specific listeriosis incidence rates. We used a meta-regression to calculate the proportions of health states, and a Monte Carlo simulation to generate DALYs by WHO subregion. FINDINGS: We screened 11 722 references and identified 87 eligible studies containing listeriosis data for inclusion in the meta-analyses. We estimated that, in 2010, listeriosis resulted in 23 150 illnesses (95% credible interval 6061-91 247), 5463 deaths (1401-21 497), and 172 823 DALYs (44 079-676 465). The proportion of perinatal cases was 20·7% (SD 1·7). INTERPRETATION: Our quantification of the global burden of listeriosis will enable international prioritisation exercises. The number of DALYs due to listeriosis was lower than those due to congenital toxoplasmosis but accords with those due to echinococcosis. Urgent efforts are needed to fill the missing data in developing countries. We were unable to identify incidence data for the AFRO, EMRO, and SEARO WHO regions.
Article
This study was aimed to screen for nisin producing Lactococcus lactis strains with prominent antimicrobial and technological characteristics applicable for the dairy industry. Twelve out of 181 Lactococcus spp. strains isolated from goat and cow milk, fermented wheat and buckwheat samples were identified as L. lactis strains harbouring nisin A, Z or novel nisin variant GLc03 genes. For the first time technological characteristics of L. lactis strains harbouring nisin variant GLc03 were evaluated. All 12 isolated strains showed clear antagonistic activity against tested food spoilage and pathogenic bacteria. Moreover, strains encoding nisin Z presented favourable enzymatic activities of acid phosphatase, esterase lipase and phosphohydrolase. However, strains encoding novel nisin variant GLc03 were lacking appropriate technological characteristics being resistant to tetracycline and producing harmful β-glucosidase, therefore these strains are not applicable for the dairy food production. Two nisin A producing L. lactis strains were poor acidifiers and one strain showed resistance to tetracycline. Three strains were selected according to safety and technological criteria and were examined in fresh cheese production for control of Listeria monocytogenes growth. Listeria numbers were significantly reduced (P < 0.001) in model cheese suggesting the application of these strains for fresh cheese safety improvement.
Article
Dairy products, in particular soft cheeses, pose a major concern to the dairy industry and public health authorities as they are the leading source of listeriosis outbreaks, a severe foodborne infection affecting pregnant women, children, elderly and immunocompromised people, with a high (20–30%) mortality rate. Cheeses offer a suitable environment for the survival and growth of Listeria monocytogenes, allowing this pathogen to display tolerance responses that can favour its presence in cheese and persistence in dairy processing plants. Extensive food safety regulations in the EU towards prevention of contamination of dairy products with L. monocytogenes have been implemented. However due to the specific abilities of this pathogen to overcome the processing hurdles, its control remains a challenge. Compliance with the Good Manufacturing Practices, observation of Hazard Analysis Critical Control Points (HACCP) and the surveillance of the pathogen in the cheese processing environment are crucial to provide consumers with a safe product. This review aims to provide an overview on the current knowledge about the potential for the transmission of L. monocytogenes in cheese and its abilities to overcome the challenging processing conditions and implications for the behaviour of the pathogen in the host.
Article
Bacteriocin-producing Enterococcus faecalis INIA 4 was used as adjunct lactic culture at inoculum levels ranging from 0.003% to 0.10% in the manufacture of semi-hard cheese. Cheese made from milk with 0.003% adjunct culture had the most pronounced proteolysis and developed a characteristic cheese flavour faster than the rest, reaching in 30.4 days the flavour intensity score of a 45-day control cheese made without adjunct culture.